MEDITULIP Co., Ltd.

Based in Cheongju, South Korea, and founded in 2015, MEDITULIP Co. , Ltd. develops medical devices for surgery, such as automatic endoscopic suturing machines and implantable medicine injectors. The company established a branch in Shanghai, China in 2016 and obtained a factory site within the Osong Bio-Health Science Technopolis, and start to manufacture products in 2018.

The company developed a Novel Asymmetrical Linear Stapler or NALS, an endoscopic linear stapler that enables surgeons to take tissue samples for frozen section biopsy from the true resection margin and to confirm the radicality of cancer surgery intraoperatively. Another product of the company is TULIP PORT, a chemoport to maximize patient comfort and safety by making the housing thin and small and the septum wide yet pressure-resistant. It is power-injectable and supports X-ray, CT, and MRI examinations. MEDITULIP also distributes innovative products from abroad through its subsidiary Meditulip Global, Inc.

MEDITULIP will continue to make a second and a third surgical history through continuous research and development based on the company's clinical focus and development skills in order to contribute to human welfare through continuous innovation, services, and donations.